Canaccord downgrades St. Jude Medical (STJ) to Sell citing "questionable earnings quality," a...

|About: St. Jude Medical, Inc. (STJ)|By:, SA News Editor

Canaccord downgrades St. Jude Medical (STJ) to Sell citing "questionable earnings quality," a less-than-enthusiastic take on the company's product pipeline, the potential for CRM market share loss, and an "overextended valuation." Price target maintained at $35.

Subscribe for full text news in your inbox